EA200301151A1 - Вакцина против натуральной оспы - Google Patents

Вакцина против натуральной оспы

Info

Publication number
EA200301151A1
EA200301151A1 EA200301151A EA200301151A EA200301151A1 EA 200301151 A1 EA200301151 A1 EA 200301151A1 EA 200301151 A EA200301151 A EA 200301151A EA 200301151 A EA200301151 A EA 200301151A EA 200301151 A1 EA200301151 A1 EA 200301151A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dash
vaccine against
against natural
vaccines
smallpox
Prior art date
Application number
EA200301151A
Other languages
English (en)
Other versions
EA007656B1 (ru
Inventor
Рихард А. Вельцин
Томас П. Монат
Original Assignee
Экэмбис, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Экэмбис, Инк. filed Critical Экэмбис, Инк.
Publication of EA200301151A1 publication Critical patent/EA200301151A1/ru
Publication of EA007656B1 publication Critical patent/EA007656B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24161—Methods of inactivation or attenuation

Abstract

Изобретение относится к вакцинам на основе аттенуированного вируса осповакцины, которые можно использовать для профилактики или лечения натуральной оспы у человека, а также к способам получения таких вакцин.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200301151A 2001-04-23 2002-04-23 Клонированный штамм вируса осповакцины, способ его получения и применение штамма в качестве вакцины EA007656B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/840,751 US6723325B1 (en) 2001-04-23 2001-04-23 Smallpox vaccine
PCT/US2002/012616 WO2002085411A1 (en) 2001-04-23 2002-04-23 Smallpox vaccine

Publications (2)

Publication Number Publication Date
EA200301151A1 true EA200301151A1 (ru) 2004-10-28
EA007656B1 EA007656B1 (ru) 2006-12-29

Family

ID=25283120

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200301151A EA007656B1 (ru) 2001-04-23 2002-04-23 Клонированный штамм вируса осповакцины, способ его получения и применение штамма в качестве вакцины

Country Status (20)

Country Link
US (2) US6723325B1 (ru)
EP (1) EP1381389B1 (ru)
JP (1) JP4397591B2 (ru)
KR (1) KR20040063083A (ru)
CN (1) CN1527722A (ru)
AU (1) AU2002258910B2 (ru)
BR (1) BR0209145A (ru)
CA (1) CA2444747C (ru)
CZ (1) CZ305819B6 (ru)
EA (1) EA007656B1 (ru)
ES (1) ES2546612T3 (ru)
HK (1) HK1062804A1 (ru)
HU (1) HU228401B1 (ru)
IL (2) IL158549A0 (ru)
MA (1) MA26270A1 (ru)
MX (1) MXPA03009711A (ru)
NZ (1) NZ529265A (ru)
PL (1) PL212117B1 (ru)
WO (1) WO2002085411A1 (ru)
ZA (1) ZA200309084B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7645456B2 (en) * 2001-04-23 2010-01-12 Sanofi Pasteur Biologics Co. Vaccinia virus strains
US6723325B1 (en) * 2001-04-23 2004-04-20 Acambis, Inc. Smallpox vaccine
WO2006113927A2 (en) * 2005-04-20 2006-10-26 University Of Washington Immunogenic vaccinia peptides and methods of using same
AR063606A1 (es) 2006-11-07 2009-02-04 Acambis Inc Estabilizacion de vacunas mediante liofilizacion
KR100859345B1 (ko) * 2006-12-12 2008-09-19 씨제이제일제당 (주) 세포배양에 의해 두창 백신을 생산하는 방법 및 그에 의해생산된 두창 백신
EP2697368B1 (en) 2011-04-15 2019-06-05 Genelux Corporation Clonal strains of attenuated vaccinia viruses and methods of use thereof
RU2496149C1 (ru) * 2012-06-19 2013-10-20 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") Способ оценки противооспенной активности лечебно-профилактических препаратов
CA3042694A1 (en) 2016-11-02 2018-05-11 David Evans Synthetic chimeric poxviruses
US11505782B2 (en) 2018-06-04 2022-11-22 Calidi Biotherapeutics, Inc. Cell-based vehicles for potentiation of viral therapy
AU2019377141A1 (en) 2018-11-06 2021-05-20 Calidi Biotherapeutics, Inc. Enhanced systems for cell-mediated oncolytic viral therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
JPS60202827A (ja) 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
US5614193A (en) * 1991-11-14 1997-03-25 The United States Of America As Represented By The Secretary Of The Army Hantavirus vaccine
US5656465A (en) * 1994-05-04 1997-08-12 Therion Biologics Corporation Methods of in vivo gene delivery
US6723325B1 (en) 2001-04-23 2004-04-20 Acambis, Inc. Smallpox vaccine

Also Published As

Publication number Publication date
EA007656B1 (ru) 2006-12-29
PL373958A1 (en) 2005-09-19
MA26270A1 (fr) 2004-09-01
PL212117B1 (pl) 2012-08-31
HK1062804A1 (en) 2004-11-26
JP2005503126A (ja) 2005-02-03
AU2002258910B2 (en) 2007-10-25
CN1527722A (zh) 2004-09-08
ES2546612T3 (es) 2015-09-25
CA2444747C (en) 2018-04-17
HUP0303878A3 (en) 2010-01-28
HUP0303878A2 (hu) 2004-03-01
CZ305819B6 (cs) 2016-03-30
HU228401B1 (en) 2013-03-28
JP4397591B2 (ja) 2010-01-13
EP1381389A1 (en) 2004-01-21
NZ529265A (en) 2006-04-28
BR0209145A (pt) 2005-04-19
KR20040063083A (ko) 2004-07-12
WO2002085411A1 (en) 2002-10-31
IL158549A (en) 2009-07-20
US7115270B2 (en) 2006-10-03
CZ20033184A3 (cs) 2004-04-14
US20060153873A1 (en) 2006-07-13
CA2444747A1 (en) 2002-10-31
ZA200309084B (en) 2005-01-26
IL158549A0 (en) 2004-05-12
EP1381389A4 (en) 2004-07-28
MXPA03009711A (es) 2005-03-07
EP1381389B1 (en) 2015-08-26
US6723325B1 (en) 2004-04-20

Similar Documents

Publication Publication Date Title
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
ATE426412T1 (de) Adjuvante influenza-vakzine
CY1105389T1 (el) Hpv-e7 ως αγωγη εναντι του ιου θηλωματων ανθρωπου
LU92311I2 (fr) Virus de la vaccine ankara vivant modifié
MX2023000411A (es) Vacuna combinada de sars-cov-2 e influenza.
DE60226911D1 (de) Entwicklung einer Vakzine zur Prävention von Infektionen mit Filovirus bei Primaten
HK1083192A1 (en) West nile virus vaccine
WO2003101397A3 (en) Tetravalent dengue vaccines
EA200700904A1 (ru) Вакцины против вируса японского энцефалита и вируса западного нила
WO2006076003A3 (en) Vaccinia virus strains
DK1326633T3 (da) Sammensætning omfattende immunogene mikropartikler
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
CY1114614T1 (el) Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα
EA200301151A1 (ru) Вакцина против натуральной оспы
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
DK1425404T3 (da) Vaccinia-MVA-E3L-mutanter og anvendelse deraf
DE60124526D1 (de) Methode zur identifizierung von helicobacter antigenen
DK1290160T3 (da) Humane Pellino-polypeptider
WO2005023849A3 (en) Antigenic peptides of rabies virus and uses thereof
ATE471990T1 (de) Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln
BR0111785A (pt) Composições e métodos para tratamento de candidìase
ATE455854T1 (de) Rekombinante mva-stamme als potentielle impfstoffe gegen p. falciparum -malaria
DE60224280D1 (de) Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis
EA200400534A1 (ru) Стимуляция тимозином генетической иммунизации

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU